Concentra Group Holdings Parent, Inc. CON 深 沪
交易中 04-01 10:44:58 美东时间
21.26
-0.190
-0.89%
华盛通- 最 高21.49
- 今 开21.49
- 成交量 3.58万股
- 最 低 21.195
- 昨 收 21.45
- 总市值 27.32亿
- 52周最高 24.6225
- 市盈率 静 16.61
- 换手率 0.00%
- 52周最低 18.42
- 委 比 27.52%
- 总股本 1.29亿
- 历史最高 24.6225
- 量 比 0.29
- 振 幅 1.38%
- 历史最低 18.42
- 每 手 1
- 风险率 1.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 最高582美元！博通获多家机构上调目标价；GENI、Okta、Rigetti Computing、Veeva Systems、Wix.com遭多家机构下调目标价
今日重点评级关注：韦德布什：维持TScan Therapeutics"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持莱斯康制药"买入"评级，目标价从4美元升至6美元
03-06 11:58
Concentra Group Holdings Sees FY2026 Sales $2.250B-$2.350B vs $2.318B Est
Concentra Group Holdings (NYSE:CON) sees FY2026 sales of $2.250 billion-$2.350 billion vs $2.318 billion analyst estimate.
02-27 05:32
Concentra Group Holdings Q4 Earnings Report: What Investors Need to Know
Concentra Group Holdings (NYSE:CON) just disclosed its Q4 earnings on Thursday,...
02-27 05:32
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
美股大行评级 | 高露洁棕榄、再生元制药、伊士曼化工、威瑞森、Ameris、丘奇＆德怀特等获多家大行上调目标价
今日重点评级关注：Benchmark：维持Charter Communications"买入"评级，目标价从425美元升至455美元；BTIG：维持LifeStance Health Gr"买入"评级，目标价从10美元升至11美元
02-03 09:06
RBC Capital Maintains Outperform on Concentra Group Holdings, Raises Price Target to $31
RBC Capital analyst Ben Hendrix maintains Concentra Group Holdings (NYSE:CON) with a Outperform and raises the price target from $30 to $31.
02-03 00:51
Concentra Group Holdings Raises FY2025 Sales Guidance from $2.130B-$2.160B to $2.145B-$2.160B vs $2.148B Est
2025 Business OutlookConcentra raised its financial guidance for 2025. We now expect to deliver the following results:Revenue in the range of $2.145 billion to $2.160 billionAdjusted EBITDA in the range of $425 million
2025-11-07 05:32
美股大行评级 | 上调！CrowdStrike、Lyft、MongoDB、Roivant等多只热门股获大行齐上调目标价
今日重点评级关注：Needham：上调爱美医疗评级至"买入"，目标价14美元；高盛：维持Roivant Sciences"买入"评级，目标价从20美元升至24美元
2025-09-19 09:18
Aveanna upgraded at J.P. Morgan on risk-reward setup
J.P. Morgan upgraded Aveanna Healthcare (NASDAQ:AVAH) to Neutral from Underweight and raised its Dec. 26 price target to $10 from $6 on Thursday, noting a balanced risk-reward setup for the home healt...
2025-09-19 00:20
JP Morgan Assumes Concentra Group Holdings at Overweight, Announces Price Target of $31
JP Morgan analyst Benjamin Rossi assumes Concentra Group Holdings (NYSE:CON) with a Overweight rating and announces Price Target of $31.
2025-09-18 19:00
